Merck is a major pharmaceutical company anchored by the cancer blockbuster Keytruda. It trades on NYSE under the ticker MRK, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | MRK |
| Exchange | NYSE |
| Sector | Pharmaceuticals |
| Headquarters | Rahway, NJ, USA |
Bull Case & Risks
Bull Case
- Keytruda oncology leadership
- Breadth across pipeline and vaccines
- Strong cash flow
Risks
- A looming Keytruda patent cliff
- Pipeline-replacement risk
Outlook
Merck’s near-term strength is Keytruda, so the investment case hinges on whether its pipeline can replace that revenue before patent expiry.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.